Please login to the form below

Not currently logged in
Email:
Password:

Mimpara

This page shows the latest Mimpara news and features for those working in and with pharma, biotech and healthcare.

NICE set to back Parsabiv for kidney disease complication

NICE set to back Parsabiv for kidney disease complication

be treated with Amgen's older drug Sensipar/Mimpara (cinacalcet) - and provided Amgen supplies the drug at an agreed discount.

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • PAN and DJM win prestigious Global Award

    Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their animation of Mimpara Man’ for Amgen. ... Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics